The medium and long-term impacts of COVID-19 on cancer care
Guy Jerusalem, MD, PhD, University of Liège, Liège, Belgium, discusses the medium and long-term impact of COVID-19 on cancer care….
Related Articles
Post-ASCO 2024 Highlights
Webinar series by VJOncology from 19–24 June 2024 featuring presentations & discussions on selected abstracts from ASCO 2024
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Challenges in timely assessment and access to care for lung cancer
Mariana Brandao, MD, PhD, from the Institute Jules Bordet in Brussels, Belgium, discusses the challenges in timely assessment and access to care for patients with…
Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis
Gerard Walls, MB MRCP MSc FRCR, Queens University in Belfast, UK, discusses the NI-HEART analysis aimed at addressing the challenges of collecting cardiac toxicity events…
Exploring novel therapeutics in lung cancer: insights from BTOG 2024
Adam Januszewski, St Bartholomew’s Hospital in London, provides an overview of a session he chaired at the BTOG 2024 congress focusing on therapeutics, particularly exploring…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
SECOMBIT: treatment sequencing in metastatic melanoma and incidence of brain metastasis
Georgina V. Long, PhD, MBBS, FRACP, FAHMS, The University of Sydney, North Sydney, Australia, discusses the Phase II SECOMBIT (NCT02631447) trial, which evaluated the best…
Will enfortumab vedotin and pembrolizumab be the new SOC in urothelial cancer?
Enrique Grande, MD, PhD, MD Anderson Cancer Centre Madrid, Madrid, Spain, discusses the implications of the findings from the EV-302 trial (NCT04223856) of enfortumab vedotin,…
Colonoscopy: primary screening with evolving challenges
Aasma Shauka, MD, MPH, New York University, New York, NY, discusses the current landscape of colonoscopy screening in the United States. Colonoscopy is the primary…